CLOV vs TPCS
Clover Health Investments Corp (CLOV) versus TechPrecision Corporation Common stock (TPCS) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
TechPrecision Corporation Common stock (TPCS) is a metal fabrication company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported TPCS revenue for 2025-03-31 was $34.0M. Net income was -$2.7M. Revenue was up 7.7% from 2024-03-31 to 2025-03-31. TPCS currently screens at market cap $34.5M.
CLOV currently screens at market cap $1.55B. TPCS currently screens at market cap $34.5M.
Not investment advice. Open the CLOV and TPCS stock pages for the full models.
Not investment advice.